Reata Pharmaceuticals DPO Ratio 2011-2026 | RETA

Annual DPO Ratio Reata Pharmaceuticals

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	5.6	-	-	-	-	-	-	-	-

All numbers in USD currency

Maximum	Minimum	Average
5.6	5.6	5.6

Issuer	DPO Ratio	Price	% 24h	Market Cap	Country
AstraZeneca PLC AZN	265	-	-	$ 96.9 B	Britain
Celldex Therapeutics CLDX	4.06 K	$ 34.55	2.04 %	$ 2.29 B	USA
I-Mab IMAB	2.24 K	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	78.2	-	-	$ 40.3 B	USA
Alnylam Pharmaceuticals ALNY	55	$ 309.66	-3.27 %	$ 40.6 B	USA
Midatech Pharma plc MTP	162	-	-18.52 %	$ 27.3 M	Britain
Amphastar Pharmaceuticals AMPH	31.7	$ 22.88	4.91 %	$ 1.07 B	USA
Институт стволовых клеток человека ISKJ	115	-	-	-	Russia
Advaxis ADXS	143 K	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	34.4 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	9.04 K	-	-10.17 %	$ 12.2 K	USA
BioXcel Therapeutics BTAI	34.2 K	$ 1.15	7.48 %	$ 14 M	USA
Akebia Therapeutics AKBA	168	$ 1.41	4.07 %	$ 363 M	USA
Ayala Pharmaceuticals AYLA	2.21 K	-	-	$ 7.46 M	Israel
Aquestive Therapeutics AQST	395	$ 4.32	1.41 %	$ 462 M	USA
Arcutis Biotherapeutics ARQT	133	$ 24.53	1.41 %	$ 3.12 B	USA
AIkido Pharma AIKI	1.92	-	1.93 %	$ 17.4 M	USA
BioDelivery Sciences International BDSI	96.3	-	-4.8 %	$ 255 M	USA
Autolus Therapeutics plc AUTL	9.57	$ 1.6	-0.62 %	$ 426 M	Britain
BeiGene, Ltd. BGNE	915	-	0.49 %	$ 251 B	Cayman-islands
bluebird bio BLUE	182	-	-	$ 546 M	USA